Table 3.
AR patients (n=7) | ||||||
---|---|---|---|---|---|---|
| ||||||
FEV1 (liters) | FVC (liters) | FEV1/FVC | ||||
| ||||||
Before | After | Before | After | Before | After | |
RA | 3.12 ± 0.28 | 2.99 ± 0.25 | 3.84 ± 0.35 | 3.78 ± 0.32 | 81.26 ± 2.01 | 79.44 ± 1.37 |
HA | 3.12 ± 0.30 | 3.08 ± 0.30 | 3.82 ± 0.37 | 3.92 ± 0.36† | 82.09 ± 2.12 | 78.31 ± 1.44* |
Healthy subjects (n=6) | ||||||
---|---|---|---|---|---|---|
| ||||||
FEV1 (liters) | FVC (liters) | FEV1/FVC | ||||
| ||||||
Before | After | Before | After | Before | After | |
RA | 3.67 ± 0.32 | 3.63 ± 0.32 | 4.50 ± 0.44 | 4.54 ± 0.44 | 82.07 ± 2.26 | 80.43 ± 2.56 |
HA | 3.66 ± 0.33 | 3.63 ± 0.33 | 4.46 ± 0.46 | 4.53 ± 0.49 | 82.52 ± 2.39 | 80.96 ± 2.47 |
Forced expiratory tests were performed before and at ~8 minutes after the hyperventilation challenge in allergic rhinitis (AR) patients and healthy subjects.
Significant difference between before and after the hyperventilation challenge.
Significant different from the corresponding RA data.